Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 554.99% | -1,666.13% | -4,880.69% | -386.68% | -281.34% |
| Total Depreciation and Amortization | 61.48% | 21.22% | 10.00% | 18.21% | 16.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -851.24% | 47,352.40% | 1,069.24% | 831.63% | 156.94% |
| Change in Net Operating Assets | -45.79% | 175.10% | -102.78% | 294.01% | -201.97% |
| Cash from Operations | -20.18% | 23.72% | 15.81% | 51.51% | 29.14% |
| Capital Expenditure | 88.59% | 36.36% | -167.53% | 28.82% | 89.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.59% | 36.36% | -167.53% | 28.82% | 89.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -350.00% | -- | 47.54% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -93.58% | -- | 24,637.70% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 360.84% | -325.57% | 22.70% | 212.56% | 35.75% |